Ludwig Cancer Research

Dec 19, 2019

Rafael Holdings Launches Cancer Drug Development Initiative

Oct 11, 2018

Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City Today, 11 October, 2018

Jul 09, 2018

Polaris Announces Dr. Chi Van Dang Joining its Scientific Advisory Board

Jun 20, 2018

VIVES Portfolio Company iTeos Therapeutics, a Spin-Off of UCL and LICR, Strengthened by an Oversubscribed Series B Fundraising of 64 Million Euros

Mar 08, 2018

Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company

Jan 08, 2018

NeoPhore Appoints Pioneering Cancer Researchers and Clinicians to Scientific Advisory Board

Nov 15, 2017

PhoreMost and Sixth Element Capital Announce Creation and Investment in NeoPhore, an Immuno-Oncology Company

Oct 23, 2017

CytoSen Therapeutics Appoints CEO and Scientific Advisory Board

Aug 17, 2017

ViraCyte Awarded $8.99M from the Cancer Prevention and Research Institute of Texas

Jun 22, 2017

The Parker Institute for Cancer Immunotherapy Trains the Next Generation of Scientific Leaders in Cancer Immunotherapy